Date Filed | Type | Description |
07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/27/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/06/2023 |
4
| FROST PHILLIP MD ET AL (10% Owner) has filed a Form 4 on Cocrystal Pharma, Inc.
Txns:
| Bought 1,015,229 shares
@ $1.97, valued at
$2M
|
|
08/03/2022 |
4
| Japour Anthony J (Director) has filed a Form 4 on Cocrystal Pharma, Inc.
Txns:
| Granted 148,000 options to buy
@ $0.42, valued at
$62.2k
|
|
08/03/2022 |
4
| Martin James Joseph (Co- Interim CEO and CFO) has filed a Form 4 on Cocrystal Pharma, Inc.
Txns:
| Granted 300,000 options to buy
@ $0.42, valued at
$126k
|
|
08/03/2022 |
4
| PFENNIGER RICHARD C JR (Director) has filed a Form 4 on Cocrystal Pharma, Inc.
Txns:
| Granted 80,000 options to buy
@ $0.42, valued at
$33.6k
|
|
08/03/2022 |
4
| FROST PHILLIP MD ET AL (Director) has filed a Form 4 on Cocrystal Pharma, Inc.
Txns:
| Granted 220,000 options to buy
@ $0.42, valued at
$92.4k
|
|
08/03/2022 |
4
| Rubin Steven D (Director) has filed a Form 4 on Cocrystal Pharma, Inc.
Txns:
| Granted 188,000 options to buy
@ $0.42, valued at
$79k
|
|
08/03/2022 |
4
| Kornberg Roger D. (Director) has filed a Form 4 on Cocrystal Pharma, Inc.
Txns:
| Granted 280,000 options to buy
@ $0.42, valued at
$117.6k
|
|
08/03/2022 |
4
| Lee Sam (President and Co-Interim CEO) has filed a Form 4 on Cocrystal Pharma, Inc.
Txns:
| Granted 300,000 options to buy
@ $0.42, valued at
$126k
|
|
08/23/2021 |
4
| PFENNIGER RICHARD C JR (Director) has filed a Form 4 on Cocrystal Pharma, Inc.
Txns:
| Bought 40,000 shares
@ $1.028, valued at
$41.1k
|
|
07/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/20/2021 |
4
| Kornberg Roger D. (Director) has filed a Form 4 on Cocrystal Pharma, Inc.
Txns:
| Granted 65,000 options to buy
@ $1.11, valued at
$72.2k
|
|
07/20/2021 |
4
| Martin James Joseph (CFO) has filed a Form 4 on Cocrystal Pharma, Inc.
Txns:
| Granted 250,000 options to buy
@ $1.11, valued at
$277.5k
|
|
07/20/2021 |
4
| Rubin Steven D (Director) has filed a Form 4 on Cocrystal Pharma, Inc.
Txns:
| Granted 88,000 options to buy
@ $1.11, valued at
$97.7k
|
|
07/20/2021 |
4
| Japour Anthony J (Director) has filed a Form 4 on Cocrystal Pharma, Inc.
Txns:
| Granted 74,000 options to buy
@ $1.11, valued at
$82.1k
|
|
07/20/2021 |
4
| Lee Sam (President and Co-Interim CEO) has filed a Form 4 on Cocrystal Pharma, Inc.
Txns:
| Granted 250,000 options to buy
@ $1.11, valued at
$277.5k
|
|
07/20/2021 |
4
| FROST PHILLIP MD ET AL (Director) has filed a Form 4 on Cocrystal Pharma, Inc.
Txns:
| Granted 65,000 options to buy
@ $1.11, valued at
$72.2k
|
|
06/02/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
05/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/24/2020 |
4
| WILCOX GARY (CEO) has filed a Form 4 on Cocrystal Pharma, Inc.
Txns:
| Granted 200,000 options to buy
@ $1.33, valued at
$266k
|
|
06/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|